[CNP_O1] Oral Session 1

Fri. Oct 11, 2019 8:40 AM - 10:20 AM Room 9 (405)

座長：高橋　一志（東京女子医科大学神経精神科）

+Add all to schedule

8:40 AM - 9:00 AM

[CNP-O1-1] The relationship between clozapine ultra slow titration and safety: a single-center retrospective cohort study

^○Masaru TSUKAHARA, Ryuhei SO (Okayama Psychiatric Medical Center)

9:00 AM - 9:20 AM

[CNP-O1-2] Cost-effectiveness of screening for HLA-B*59:01 prior to initiation of clozapine.

^○Kohei NINOMIYA, Nakao IWATA, Ikeda MASASHI, Tomo OKOCHI, Takeo SAITO, Satoru TANIGUCHI, Rei AOKI (Department of Psychiatry, Fujita Health University School of Medicine)

9:20 AM - 9:40 AM

[CNP-O1-3] To investigate the relationship between Clozapine and eosinophilic pneumonia retrospectively in Japanese treatment-resistant schizophrenia patients

^○Masaru NAKAMURA¹, Takahiko NAGAMINE ² (1. Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima, Japan, 2. Sunlight Brain Research Center, Yamaguchi, Japan.)

9:40 AM - 10:00 AM

[CNP-O1-4] A model-based analysis of steady-state plasma clozapine and norclozapine concentrations and their ratio in Japanese Schizophrenia patients

^○Kazuya MORITA¹, Yumiko AKAMINE², Masahiko MIKUNI^{3, 7}, Toshihide KUROKI^{4, 7}, Hiroshi KUNUGI^{5, 7}, Kentaro ONIKI¹, Junji SARUWATARI¹, Norio FURUKORI^{6, 7} (1. Department of Pharmacology and Therapeutics, Kumamoto University, Kumamoto, Japan, 2. department of pharmacy, Akita University Hospital, 3. Hakodate Watanabe Hospital, 4. Graduate School of Human-Environment Studies, Kyushu University, 5. Department of Mental Disorder Research, National Institute of Neuroscience, 6. Department of Psychiatry, Dokkyo Medical University, 7. Research team on database construction for treatment strategies for treatment-resistant schizophrenia )